RebeccaLeighKingMD

PubMed

• Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients.
  Marie-France Gagnon, Daniel R Sill, Reid G Meyer, Patricia T Greipp, Nicole L Hoppman, Xinjie Xu, Linda B Baughn, Frido K Bruehl, Jess F Peterson, Ellen D McPhail, Rhe...> ;Journal of Hematopathology. 2024 Apr 2
• Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments.
  Jordan E Krull, Kerstin Wenzl, Melissa A Hopper, Michelle K Manske, Vivekananda Sarangi, Matthew J Maurer, Melissa C Larson, Patrizia Mondello, ZhiZhang Yang, Joseph P...> ;Cell Reports. Medicine. 2024 Mar 19
• Genetics and pathologic landscape of lineage switch of acute leukemia during therapy.
  Zhou, T., Curry, C., Khanlari, M., Shi, M., Cui, W., Peker, D., Chen, W., Wang, E., Gao, J., Shen, Q., Xie, W., Jelloul, F., King, R., Yuan, J., Wang, X., Zhao, C., Ob...> ;Blood Cancer Journal. 2024 Jan 25
• Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis.
  Gagnon, M., Penheiter, A., Harris, F., Johnson, S., Karagouga, G., McCune, A., Zepeda-Mendoza, C., Greipp, P., Xu, X., Vasmatzis, G., Baughn, L., Sadeghian, D., Ketter...> ;Blood Cancer Journal. 2023 Dec 19
• Immune Checkpoint Inhibitor-Induced Pure Red Cell Aplasia: A Review of 2 Cases in Metastatic Melanoma.
  Libardo Rueda Prada, Tatjana Gavrancic, Miguel O Cadena Sanabria, Igor Dumic, Kirk Bourgeois, Rebecca L King, Yiyi Yan> ;The American Journal of Case Reports. 2023 Nov 14
• Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients.
  Ji Yuan, Hui Liu, Shimin Hu, Roberto N Miranda, Xinjie Xu, Michael G Bayerl, Cody J Artymiuk, Holly Berg, Rebecca L King, Min Shi, Rong He, David Viswanatha, L Jeffrey...> ;Human Pathology. 2023 Nov 1
• Central nervous system involvement (Bing-Neel Syndrome) in patients with Waldenström macroglobulinemia.
  Saurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, Morie A Gertz, Michelle Mauermann, Thomas E Witzig, Patrick Johnston, Robert A Kyle, Rebecca L King, Thomas M Habe...> ;Leukemia & Lymphoma. 2023 Jun 10
• 4 citations
  Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
  Karan L Chohan, Jonas Paludo, Nishanth Vallumsetla, Dirk Larson, Rebecca L King, Rong He, Wilson Gonsalves, David Inwards, Thomas E Witzig, Abhisek Swaika, Tania Jain,...> ;American Journal of Hematology. 2023 Mar 1
• Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis.
  Sanjal H Desai, Raphael Mwangi, Rebecca L King, Matthew J Maurer, James R Cerhan, Andrew L Feldman, Umar Farooq, Eric Mou, Thomas M Habermann, Carrie A Thompson, Yucai...> ;Blood Advances. 2022 Dec 27
• 54 citations
  Genomic profiling for clinical decision making in lymphoid neoplasms.
  Laurence de Leval, Ash A Alizadeh, P Leif Bergsagel, Elias Campo, Andrew Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M Horwitz, Ari M Melnick, William G Morice, Ryan ...> ;Blood. 2022 Nov 24
• 1 citations
  Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma.
  Sanjal H Desai, Raphael Mwangi, Alexandra N Smith, Matthew J Maurer, Umar Farooq, Rebecca L King, James R Cerhan, Andrew L Feldman, Thomas M Habermann, Carrie A Thomps...> ;Hematological Oncology. 2023 Feb 1
• 7 citations
  Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities.
  Thomas A Tousseyn, Rebecca L King, Falko Fend, Andrew L Feldman, Pierre Brousset, Elaine S Jaffe> ;Virchows Archiv. 2023 Jan 1
• 13 citations
  Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status.
  Jithma P Abeykoon, Karen L Rech, Jason R Young, Aishwarya Ravindran, Gordon J Ruan, Surendra Dasari, Diana M Morlote, Rebecca L King, Claire Rummage, Saurabh Zanwar, A...> ;JAMA Oncology. 2022 Dec 1
• 435 citations
  The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
  Elias Campo, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Martinez, Steven H Swerdlow, Kenneth C Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, St...> ;Blood. 2022 Sep 15
• Primary Leptomeningeal Lymphoma: Clinicopathologic Features of 2 Rare Phenotypes.
  M Adelita Vizcaino, Caterina Giannini, Rebecca L King, Derek R Johnson, Tong Yang, Aditya Raghunathan> ;Journal of Neuropathology and Experimental Neurology. 2022 Nov 16
• 14 citations
  Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma.
  Rebecca L King, Eric D Hsi, Wing C Chan, Miguel A Piris, James R Cook, David W Scott, Steven H Swerdlow> ;Virchows Archiv. 2023 Jan 1
• 1 citations
  Plasmablastic lymphoma with MYC::IGH fusion and BCL2 rearrangement.
  Mohammad Barouqa, Patricia Greipp, Rebecca King, Ellen D McPhail> ;Ejhaem. 2022 Aug 1
• 1 citations
  Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma.
  Paul J Kurtin, Rebecca L King, Ji Yuan, Andrew L Feldman, Karen L Rech, Ellen D McPhail, Sameer A Parikh, Wei Ding, Min Shi, Ravindran, A.> ;Human Pathology. 2022 Jul 1
• Cyto-histologic correlation of crystal-storing histiocytosis: Rare presentation in breast, predating diagnosis of B-cell lymphoma by two years.
  Mohammed Firwana, Anna-Lee Clarke-Brodber, Rebecca L King, Joanna C Dalland, Christopher P Hartley, Nicholas A Boire, Charles D Sturgis> ;Annals of Diagnostic Pathology. 2022 Aug 1
• 1 citations
  PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.
  Sanjal H Desai, Levi Pederson, Betsy LaPlant, Raphael Mwangi, Matthew Maurer, Jason R Young, William R Macon, Rebecca L King, Yucai Wang, James R Cerhan, Andrew Feldma...> ;Blood Cancer Journal. 2022 May 3
• 4 citations
  The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease.
  Pedro Horna, Rebecca L King, Dragan Jevremovic, David C Fajgenbaum, Angela Dispenzieri> ;Haematologica. 2023 Jan 1
• 8 citations
  Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
  Rebecca L King, Alia Gupta, Paul J Kurtin, Wei Ding, Timothy G Call, Kari G Rabe, Saad S Kenderian, Jose F Leis, Yucai Wang, Susan M Schwager, Susan L Slager, Neil E K...> ;Blood Cancer Journal. 2022 Jan 28
• Diffuse Large B-Cell Lymphoma of Peripheral Nerve with Distinctive Pathological Features Resembling Primary CNS Lymphoma.
  M Adelita Vizcaino, Paul J Kurtin, Rebecca L King, Robert J Spinner, Caterina Giannini> ;Journal of Neuropathology and Experimental Neurology. 2022 Jan 21
• 7 citations
  MYC break-apart FISH probe set reveals frequent unbalanced patterns of uncertain significance when evaluating aggressive B-cell lymphoma
  Marie-France Gagnon, Kathryn E. Pearce, Patricia T. Greipp, Xinjie Xu, Nicole L. Hoppman, Rhett P. Ketterling, Ellen D. McPhail, Rebecca L. King, Linda B. Baughn, Jess...> ;Blood Cancer Journal. 2021 Nov 24
• 5 citations
  Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic ...
  Rebecca L. King, Arushi Khurana, Raphael Mwangi, Angelo Fama, Kay M. Ristow, Matthew J. Maurer, William R. Macon, Stephen M. Ansell, N. Nora Bennani, Yogish C. Kudva, ...> ;Hemasphere. 2021 Sep 6
• Join now to see all

Abstracts/Posters

• Waldenstr_m Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain Amyloidosis
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clustering of Transcriptomic Signatures in Newly Diagnosed Diffuse Large B-Cell Lymphoma Identifies Two High-Risk Subgroups Which Increase in Prevalence at Relapse
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Response to Erythropoiesis Stimulating Agents in Patients with WHO-Defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytos...
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell Lymphoma
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Genomic Landscape Including Novel Mutational Drivers in Relapsed/Refractory Diffuse Large B Cell Lymphoma
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clinical Features and Treatment for Neurolymphomatosis in the Rituximab Era: Single Institution Experience
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all